TABLE 1.
Demographic and clinical characteristics of the patients in this study
| Characteristic | Result |
|---|---|
| No. of patients | 154 |
| Mean age in yr (range) | 52.4 (24-72) |
| % Male | 65.1 |
| % Female | 34.9 |
| % with underlying liver disease: | |
| Hepatitis C virus | 32.5 (50/154)a |
| Alcohol | 16.9 (26/154) |
| Hepatitis C virus and alcohol | 8.4 (13/154) |
| Autoimmune liver disease | 7.1 (11/154) |
| Primary sclerosing cholangitis | 7.1 (11/154) |
| Hepatitis B virus | 5.8 (9/154) |
| Hepatitis B and C viruses | 1.3 (2/154) |
| Cryptogenic cirrhosis | 3.2 (5/154) |
| Primary biliary cirrhosis | 3.2 (5/154) |
| Polycystic disease | 1.3 (2/154) |
| Hepatocellular carcinoma | 1.3 (2/154) |
| Other | 11.7 (18/154) |
| % with human immunodeficiency virus coinfection | 3.2 (5/154) |
| % with retransplantation | 5.2 (8/154) |
| % with immunosuppressionb | |
| Tacrolimus | 75.3 (116/154) |
| Cyclosporin A | 5.2 (8/154) |
| Mycophenolate mofetil | 5.2 (8/154) |
| Sirolimus | 11.4 (17/154) |
| Thymoglobulin | 42.0 (65/154) |
| % on dialysis | 14.3 (22/154) |
| % with rejection | 18.8 (29/154) |
| Length of ICU stay (median no. of days) | 7 |
a
No. with result/total no. in the study.
b
Some patients received more than one agent.